Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
Healthcare | Drug Related Products | Ireland
statements
IndexS&P 500 P/E33.13 EPS (ttm)1.81 Insider Own0.10% Shs Outstand135.54M Perf Week3.28%
Market Cap8.11B Forward P/E13.69 EPS next Y4.37 Insider Trans-5.27% Shs Float135.51M Perf Month0.64%
Income246.50M PEG4.14 EPS next Q1.06 Inst Own88.10% Short Float3.83% Perf Quarter22.87%
Sales4.71B P/S1.72 EPS this Y0.30% Inst Trans-0.99% Short Ratio5.28 Perf Half Y24.92%
Book/sh42.34 P/B1.41 EPS next Y8.97% ROA2.20% Target Price59.88 Perf Year23.88%
Cash/sh3.18 P/C18.82 EPS next 5Y8.00% ROE4.30% 52W Range40.68 - 60.98 Perf YTD15.87%
Dividend0.90 P/FCF27.62 EPS past 5Y-11.80% ROI0.90% 52W High-1.84% Beta1.46
Dividend %1.50% Quick Ratio1.30 Sales past 5Y3.10% Gross Margin36.80% 52W Low47.15% ATR1.46
Employees10600 Current Ratio2.10 Sales Q/Q5.10% Oper. Margin6.80% RSI (14)58.07 Volatility2.16% 2.01%
OptionableYes Debt/Eq0.58 EPS Q/Q237.20% Profit Margin5.20% Rel Volume0.51 Prev Close59.61
ShortableYes LT Debt/Eq0.58 EarningsFeb 27 BMO Payout44.10% Avg Volume983.27K Price59.86
Recom2.70 SMA201.51% SMA507.35% SMA20016.28% Volume504,513 Change0.42%
Oct-11-19Upgrade Argus Hold → Buy
Mar-20-19Initiated SunTrust Hold
Nov-13-18Downgrade Berenberg Buy → Hold
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Feb-23-20 09:42AM  Perrigo Company plc (NYSE:PRGO) Will Pay A US$0.23 Dividend In 3 Days Simply Wall St.
Feb-20-20 12:31PM  Perrigo (PRGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Feb-18-20 10:17AM  Perrigo Increases its Dividend by 7% PR Newswire
Feb-17-20 08:46AM  5 Drug/Biotech Stocks Likely to Beat Q4 Earnings Estimates Zacks
Feb-13-20 08:30AM  Perrigo To Release Fourth Quarter And Calendar Year 2019 Financial Results On February 27, 2020 PR Newswire
Feb-07-20 08:10AM  Perrigo Announces Consumer Self-Care Americas Segment Leadership Transition PR Newswire
Feb-06-20 10:11AM  Here's Why You Should Add ResMed (RMD) to Your Portfolio Zacks
09:21AM  QIAGEN Launches CE-Marked Breast Cancer Test Kit in Europe Zacks
Feb-05-20 11:40AM  PRGO or PAHC: Which Is the Better Value Stock Right Now? Zacks
Feb-03-20 04:10PM  Medtronic's Cobalt, Crome Heart Devices Portfolio Gets CE Mark Zacks
11:06AM  Align (ALGN) Rides on Volume Expansion Despite Cost Concerns Zacks
Jan-31-20 10:56AM  Here's Why You Should Hold on to Hologic (HOLX) Stock for Now Zacks
Jan-29-20 12:10PM  Will Perrigo (PRGO) Beat Estimates Again in Its Next Earnings Report? Zacks
Jan-28-20 11:18AM  Teleflex's Bipolar Temporary Pacing Guidewire Gets FDA Nod Zacks
Jan-20-20 11:40AM  PRGO vs. PAHC: Which Stock Should Value Investors Buy Now? Zacks
Jan-15-20 09:36AM  Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results Zacks
Jan-14-20 11:25AM  Perrigo stock up 9% as Leerink says sales guidance was 'particularly strong' MarketWatch +12.60%
08:47AM  Perrigo shares jump 2.8% premarket after offering above-consensus sales guidance MarketWatch
08:30AM  Perrigo To Provide Self-Care Transformation Update At J.P. Morgan Healthcare Conference; Announces Robust Preliminary Unaudited Fourth Quarter 2019 Net Sales PR Newswire
Jan-10-20 12:28PM  Are Investors Undervaluing Perrigo Company plc (NYSE:PRGO) By 50%? Simply Wall St.
Jan-07-20 01:21PM  Bernstein Litowitz Achieves Significant Victory Certifying Claims Against Perrigo (NYSE; TASE: PRGO) for Shareholders in Both the United States and Israel PR Newswire
Jan-06-20 09:00AM  Perrigo Advances Consumer Self-Care Growth Strategy with Ranir Subsidiary Acquisition of Steripod® Toothbrush Accessory Brand PR Newswire
Dec-18-19 08:22AM  Perrigo to Present at Upcoming Investor Conferences PR Newswire
Dec-16-19 10:17AM  Smashed, Smushed, Trampled: This Year's Worst Performers GuruFocus.com
Dec-12-19 06:08PM  Is Perrigo Company (PRGO) Another High Profile Starboard Failed Bet? Insider Monkey
Dec-11-19 11:08AM  Here's What Perrigo Company plc's (NYSE:PRGO) P/E Is Telling Us Simply Wall St.
Dec-06-19 11:31AM  Perrigo (PRGO) Up 4.1% Since Last Earnings Report: Can It Continue? Zacks
Dec-05-19 06:26AM  Edited Transcript of PRGO earnings conference call or presentation 6-Nov-19 1:00pm GMT Thomson Reuters StreetEvents
Dec-04-19 09:11AM  The stock market's biggest winners and losers of the past decade Yahoo Finance
Dec-02-19 04:30PM  Perrigo Announces Closing of Prevacid®24HR (OTC) Acquisition, Advancing Consumer Self-Care Growth Strategy PR Newswire
Nov-15-19 12:29PM  Q3 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios Benzinga
Nov-13-19 09:29AM  Perrigo to Present at the Morgan Stanley Global Consumer & Retail Conference PR Newswire
Nov-07-19 01:09PM  Witi, Perrigo Partner To Help Smokers Overcome Nicotine Addiction Benzinga
Nov-06-19 04:14PM  Here's One Drugmaker That Popped On Earnings And Two That Didn't Investor's Business Daily -6.72%
02:38PM  US Stocks Retreat Wednesday GuruFocus.com
12:37PM  Teva earnings preview: Opioid suits are key MarketWatch
10:56AM  Perrigo (PRGO) Beats on Q3 Earnings, Tightens '19 EPS View Zacks
07:30AM  Perrigo (PRGO) Beats Q3 Earnings Estimates Zacks
06:00AM  Perrigo Company plc Reports Third Quarter 2019 Financial Results PR Newswire
Nov-05-19 12:25PM  3 Loyal Dividend Payers Declare Distributions GuruFocus.com
10:36AM  Did You Manage To Avoid Perrigo's (NYSE:PRGO) Painful 65% Share Price Drop? Simply Wall St.
Nov-04-19 09:31AM  Perrigo Announces Quarterly Dividend PR Newswire
Nov-01-19 10:41AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Oct-30-19 10:33AM  Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to Decline Zacks
Oct-23-19 04:06PM  Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the product PR Newswire
09:01AM  Hedge Funds Are Betting On Perrigo Company plc (PRGO) Insider Monkey
Oct-22-19 06:30PM  Jerome Dodson to Speak at 2020 GuruFocus Value Conference GuruFocus.com
09:13AM  Medical Products Industry Outlook: Prospects Seem Promising Zacks
Oct-15-19 08:05AM  Perrigo Announces Third Quarter Calendar Year 2019 Earnings Date PR Newswire
Oct-11-19 11:58AM  Perrigo Company Upgraded to Buy Yahoo Finance
Oct-04-19 05:12AM  When Deal Genius Fails: Hard Lessons From 3G to SoftBank Bloomberg
Oct-03-19 05:18PM  Perrigo® Hosts 175 West Michigan Students for Manufacturing Week Celebration PR Newswire
08:00AM  Perrigo Announces the Relaunch of the AB Rated Generic Version of Transderm Scop® 1.5 MG PR Newswire
Oct-01-19 03:50PM  5 Health Care Stocks Held By Gurus GuruFocus.com
Sep-27-19 03:21PM  Read This Before Selling Perrigo Company plc (NYSE:PRGO) Shares Simply Wall St.
Sep-07-19 09:30AM  Why Is Perrigo (PRGO) Up 6.1% Since Last Earnings Report? Zacks
Sep-06-19 04:45PM  Generic Drug Stocks Latch Onto Buyout News Leading To 3-Day Rally Investor's Business Daily
12:43PM  US Stocks Gain on Friday GuruFocus.com
Sep-04-19 05:23AM  10 Most Popular Stocks for ESG Funds Investopedia
Aug-24-19 09:18AM  We Wouldn't Be Too Quick To Buy Perrigo Company plc (NYSE:PRGO) Before It Goes Ex-Dividend Simply Wall St.
Aug-22-19 07:48AM  Perrigo To Present At Upcoming Investor Conferences PR Newswire
Aug-21-19 08:42AM  Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray PR Newswire
Aug-19-19 05:15AM  The 6 Worst Health-Care Stocks So Far This Month Barrons.com
Aug-14-19 01:01PM  Does Perrigo (NYSE:PRGO) Have A Healthy Balance Sheet? Simply Wall St.
12:33PM  Edited Transcript of PRGO earnings conference call or presentation 8-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-09-19 10:09AM  PetIQ, Inc. (PETQ) Q2 2019 Earnings Call Transcript Motley Fool
09:30AM  PRGO vs. BIO: Which Stock Is the Better Value Option? Zacks
Aug-08-19 09:24PM  Perrigo (PRGO) Q2 2019 Earnings Call Transcript Motley Fool -6.80%
11:06AM  Perrigo (PRGO) Beats on Q2 Earnings and Sales, Stock Up Zacks
08:44AM  Perrigo Beats Second-Quarter Estimates but Stock Tumbles TheStreet.com
07:55AM  Perrigo (PRGO) Tops Q2 Earnings and Revenue Estimates Zacks
07:26AM  Perrigo Reports Q2 Earnings, Reaffirms Guidance Benzinga
07:06AM  Perrigo's stock surges after profit and revenue decline less than expected, outlook affirmed MarketWatch
06:30AM  Perrigo Company plc Reports Second Quarter 2019 Financial Results, Reaffirms Outlook, Progresses Consumer Transformation PR Newswire
Aug-07-19 04:50PM  Perrigo Announces Resignation Of Jeffrey C. Smith From Its Board Of Directors PR Newswire
02:36PM  Q2 Earnings Preview For Perrigo Benzinga
Aug-06-19 09:54AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Aug-01-19 10:33AM  Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-31-19 09:52AM  Perrigo Announces Quarterly Dividend PR Newswire
Jul-25-19 09:17AM  Perrigo Announces Second Quarter Calendar Year 2019 Earnings Date PR Newswire
Jul-22-19 09:30AM  PRGO or SRDX: Which Is the Better Value Stock Right Now? Zacks
Jul-13-19 09:23AM  Is There An Opportunity With Perrigo Company plc's (NYSE:PRGO) 45% Undervaluation? Simply Wall St.
Jul-10-19 01:33PM  S&P 500 index tops 3,000 for first time heres how the stock market got here and what it means MarketWatch
Jul-08-19 04:12PM  Perrigo Completes Divestiture of Animal Health Business for $185 Million PR Newswire
04:05PM  PetIQ, Inc. Completes Acquisition of Perrigo Animal Health GlobeNewswire
Jul-03-19 02:19PM  Perrigo Completes Ranir Acquisition, Raises '19 Guidance Zacks
09:17AM  Perrigo shares up 1.5% after FDA approves marketing application for generic antibacterial MarketWatch
08:37AM  Perrigo Announces FDA Final Approval and Launch Of The AB-rated Generic Version Of Metrogel-Vaginal® Gel PR Newswire
Jul-02-19 01:19PM  Perrigo Adjusts Guidance After Acquiring Ranir Global For $750M Benzinga
09:13AM  Perrigo shares up 2% after company boosts adjusted full-year EPS guidance by 10 cents MarketWatch
08:51AM  Perrigo Completes Acquisition Of Ranir, Raises Guidance PR Newswire
Jun-25-19 09:25AM  Pharmacy Stocks Rise on News Amazon is Backing Off Investopedia
Jun-18-19 10:19PM  Heres What Hedge Funds Think About Perrigo Company plc (PRGO) Insider Monkey
Jun-17-19 11:24AM  Would Perrigo Company plc (NYSE:PRGO) Be Valuable To Income Investors? Simply Wall St.
Jun-07-19 09:30AM  Why Is Perrigo (PRGO) Down 17.4% Since Last Earnings Report? Zacks
May-28-19 09:00AM  Sol-Gel Technologies Announces Seventh Agreement for Generic Product Candidates with Perrigo GlobeNewswire -5.70%
May-22-19 04:45PM  INVESTOR ALERT: Monteverde & Associates PC Launches Legal Inquiry Regarding the Acquisition PR Newswire
12:54PM  Edited Transcript of PRGO earnings conference call or presentation 9-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-21-19 09:12AM  Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren® Gel 1% PR Newswire
May-16-19 07:41AM  What Kind Of Investor Owns Most Of Perrigo Company plc (NYSE:PRGO)? Simply Wall St.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force. It operates in Europe, Australia, Israel, Mexico, the United States, Canada, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dillard James E IIIEVP, Chief Scientific OfficerFeb 07Option Exercise59.914,298257,4934,298Feb 11 08:37 AM
Needham JeffreyEVP, President CHC AmericasDec 31Option Exercise51.666,169318,69125,653Jan 03 03:47 PM
KINGMA TODD WExecutive VP, General CounselDec 20Sale54.912,300126,29329,984Dec 23 01:31 PM
Quinn GrainneEVP, Chief Medical OfficerNov 11Sale49.082,050100,6143,047Nov 13 01:33 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainNov 08Sale49.902,424120,9676,006Nov 12 11:43 AM
Needham JeffreyEVP, President CHC AmericasOct 08Option Exercise51.948,242428,08921,648Oct 10 04:12 PM
Farrington ThomasEVP and CIOOct 08Option Exercise51.946,113317,50911,693Oct 10 04:10 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainOct 08Option Exercise51.946,791352,72510,373Oct 10 04:05 PM
Kochan SharonEVP, GM InternationalOct 08Option Exercise51.947,304379,37019,493Oct 10 03:46 PM
Quinn GrainneEVP, Chief Medical OfficerOct 08Option Exercise51.945,011260,2717,704Oct 10 03:40 PM
KINGMA TODD WExecutive VP, General CounselOct 08Option Exercise51.947,486388,82334,425Oct 10 04:02 PM
Andersen SvendEVP & President CHCIOct 08Option Exercise51.947,527390,9527,527Oct 10 03:54 PM
Winowiecki RonaldCFOAug 22Sale48.0382639,6746,952Aug 23 04:15 PM
Samuels Theodore R. IIDirectorAug 09Buy46.974,000187,89311,618Aug 13 12:08 PM
Winowiecki RonaldCFOJul 19Option Exercise51.562,296118,3828,780Jul 23 12:09 PM
Karaboutis AdrianaDirectorMay 15Option Exercise0.003,97106,188May 17 04:02 PM
CLASSON ROLF ADirectorMay 15Option Exercise49.554,964245,9667,181May 17 04:00 PM
O'Connor DonalDirectorMay 15Option Exercise49.553,971196,7639,196May 17 03:58 PM
KINDLER JEFFREY BDirectorMay 15Option Exercise49.553,971196,7636,716May 17 03:57 PM
Alford Bradley ADirectorMay 15Option Exercise49.553,971196,7636,719May 17 03:54 PM
Smith Jeffrey CDirectorMay 15Option Exercise49.553,971196,7636,716May 17 03:43 PM
Samuels Theodore R. IIDirectorMay 15Option Exercise49.553,971196,7638,236May 17 03:31 PM
Parker Geoffrey M.DirectorMay 15Option Exercise49.553,971196,7637,200May 17 03:29 PM
Quinn GrainneEVP, Chief Medical OfficerFeb 26Option Exercise48.2925412,2662,826Feb 28 03:19 PM
Weninger PaulEVP, Quality OperationsFeb 26Option Exercise48.2947823,0835,212Feb 28 03:18 PM
Kochan SharonEVP, GM InternationalFeb 26Option Exercise48.291,31563,50112,937Feb 28 03:16 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainFeb 26Option Exercise48.2980438,8253,085Feb 28 03:14 PM
Needham JeffreyEVP, President CHC AmericasFeb 26Option Exercise48.291,34664,99813,760Feb 28 03:12 PM
Winowiecki RonaldCFOFeb 26Option Exercise48.2948523,4216,619Feb 28 03:10 PM
KINGMA TODD WExecutive VP, General CounselFeb 26Option Exercise48.291,93593,44127,493Feb 28 03:08 PM
Wesolowski JohnEVP, President RxFeb 26Option Exercise48.2928213,6182,527Feb 28 03:05 PM
Farrington ThomasEVP and CIOFeb 26Option Exercise48.291,07651,9605,863Feb 28 03:03 PM
open in yahoo | open in reuters | open in google